Pharmalot
Ed Silverman began writing Pharmalot at The Star Ledger of New Jersey in 2007 and it continues to this day at STAT. He joined STAT at its founding in 2015, coming from the Wall Street Journal. He has covered the pharmaceutical industry since 1995.
For more insights and analysis, bookmark this page or sign up for his newsletter here.
Latest
STAT Plus: Pharmalittle: Rite Aid files for bankruptcy; Alzheimer’s brain scans get broader Medicare coverage
STAT Plus: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin
STAT Plus: Up and down the ladder: The latest comings and goings
STAT Plus: Pharmalittle: Makers of toxic cough syrups face new actions; Cassava suffers new blow over Alzheimer’s drug
STAT Plus: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail
STAT Plus: CRO claims there was no misconduct in Lyme vaccine trial it ran for Pfizer
STAT Plus: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs
All Coverage
advertisement
